CA Patent

CA2898574A1 — Novel functionalized 4-(phenoxymethyl)-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of use

Assigned to Cortendo AB · Expires 2014-08-14 · 12y expired

What this patent protects

Embodiments of the present invention relate to 4-(phenoxymethyl)-1,3-dioxolane analogs and pharmaceutical compositions thereof having a disease-modifying action in the treatment of diseases associated with the overproduction of Cortisol that include metabolic syndrome, and any in…

USPTO Abstract

Embodiments of the present invention relate to 4-(phenoxymethyl)-1,3-dioxolane analogs and pharmaceutical compositions thereof having a disease-modifying action in the treatment of diseases associated with the overproduction of Cortisol that include metabolic syndrome, and any involving the overproduction of Cortisol.

Drugs covered by this patent

Patent Metadata

Patent number
CA2898574A1
Jurisdiction
CA
Classification
—
Expires
2014-08-14
Drug substance claim
No
Drug product claim
No
Assignee
Cortendo AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.